Apyx Medical Stock Analysis
APYX Stock | USD 1.69 0.24 16.55% |
Apyx Medical is overvalued with Real Value of 1.29 and Target Price of 7.88. The main objective of Apyx Medical stock analysis is to determine its intrinsic value, which is an estimate of what Apyx Medical is worth, separate from its market price. There are two main types of Apyx Medical's stock analysis: fundamental analysis and technical analysis.
The Apyx Medical stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Apyx Medical is usually not traded on Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day. Apyx Stock trading window is adjusted to America/New York timezone.
Apyx |
Apyx Stock Analysis Notes
About 16.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.82. Apyx Medical had not issued any dividends in recent years. Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida. Apyx Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 272 people. For more info on Apyx Medical please contact Charles II at 727 384 2323 or go to https://apyxmedical.com.Apyx Medical Quarterly Total Revenue |
|
Apyx Medical Investment Alerts
Apyx Medical is way too risky over 90 days horizon | |
Apyx Medical may become a speculative penny stock | |
Apyx Medical appears to be risky and price may revert if volatility continues | |
The company reported the previous year's revenue of 52.35 M. Net Loss for the year was (18.85 M) with profit before overhead, payroll, taxes, and interest of 29.13 M. | |
Apyx Medical currently holds about 20.06 M in cash with (5.25 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.58. | |
Roughly 16.0% of the company shares are held by company insiders | |
Latest headline from gurufocus.com: Apyx Medical Corporation to Participate in the Piper Sandler 36th Annual Healthcare Conference |
Apyx Medical Upcoming and Recent Events
Earnings reports are used by Apyx Medical to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
21st of March 2024 Upcoming Quarterly Report | View | |
9th of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
21st of March 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Apyx Largest EPS Surprises
Earnings surprises can significantly impact Apyx Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2018-05-14 | 2018-03-31 | -0.02 | -0.03 | -0.01 | 50 | ||
2017-08-02 | 2017-06-30 | -0.03 | -0.04 | -0.01 | 33 | ||
2016-10-26 | 2016-09-30 | -0.02 | -0.01 | 0.01 | 50 |
Apyx Stock Institutional Investors
Shares | Rathbone Brothers Plc | 2024-06-30 | 251.3 K | Perkins Capital Management Inc | 2024-09-30 | 217.5 K | Renaissance Technologies Corp | 2024-09-30 | 203.3 K | Bridgeway Capital Management, Llc | 2024-09-30 | 140.4 K | Kestra Advisory Services, Llc | 2024-06-30 | 124.2 K | Caption Management, Llc | 2024-09-30 | 115.5 K | State Street Corp | 2024-06-30 | 109.3 K | Dimensional Fund Advisors, Inc. | 2024-09-30 | 108.3 K | Northern Trust Corp | 2024-09-30 | 103.4 K | Archon Capital Management Llc | 2024-06-30 | 3.1 M | Royce & Associates, Lp | 2024-09-30 | 2.6 M |
Apyx Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 63.62 M.Apyx Profitablity
The company has Profit Margin (PM) of (0.58) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.46) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.46.Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.24) | (0.22) | |
Return On Capital Employed | (0.26) | (0.25) | |
Return On Assets | (0.24) | (0.22) | |
Return On Equity | (0.70) | (0.67) |
Management Efficiency
Apyx Medical has return on total asset (ROA) of (0.2183) % which means that it has lost $0.2183 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1025) %, meaning that it created substantial loss on money invested by shareholders. Apyx Medical's management efficiency ratios could be used to measure how well Apyx Medical manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to -0.22 in 2024. Return On Capital Employed is likely to rise to -0.25 in 2024. At this time, Apyx Medical's Total Assets are fairly stable compared to the past year. Non Currrent Assets Other is likely to rise to about 1.8 M in 2024, whereas Non Current Assets Total are likely to drop slightly above 8.2 M in 2024.Last Reported | Projected for Next Year | ||
Book Value Per Share | 0.78 | 0.76 | |
Tangible Book Value Per Share | 0.78 | 0.66 | |
Enterprise Value Over EBITDA | (4.72) | (4.96) | |
Price Book Value Ratio | 3.40 | 3.23 | |
Enterprise Value Multiple | (4.72) | (4.96) | |
Price Fair Value | 3.40 | 3.23 | |
Enterprise Value | 100.9 M | 66.4 M |
The strategic vision of Apyx Medical management plays a critical role in its financial performance. By evaluating this vision, we provide insights into the stock's growth potential.
Operating Margin (0.46) | Profit Margin (0.58) | Beta 1.209 | Return On Assets (0.22) | Return On Equity (1.10) |
Technical Drivers
As of the 29th of November, Apyx Medical shows the Risk Adjusted Performance of 0.0783, mean deviation of 3.48, and Downside Deviation of 3.6. Apyx Medical technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Apyx Medical Price Movement Analysis
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Apyx Medical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Apyx Medical. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Apyx Medical Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Apyx Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Apyx Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Apyx Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Apyx Medical Outstanding Bonds
Apyx Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Apyx Medical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Apyx bonds can be classified according to their maturity, which is the date when Apyx Medical has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
MPLX LP 52 Corp BondUS55336VAL45 | View | |
US03835VAH96 Corp BondUS03835VAH96 | View | |
Aptiv 435 percent Corp BondUS03835VAG14 | View | |
APTIV PLC 44 Corp BondUS03835VAF31 | View | |
APTV 31 01 DEC 51 Corp BondUS03835VAJ52 | View | |
ATR 36 15 MAR 32 Corp BondUS038336AA11 | View | |
US03836WAC73 Corp BondUS03836WAC73 | View | |
US03836WAB90 Corp BondUS03836WAB90 | View |
Apyx Medical Predictive Daily Indicators
Apyx Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Apyx Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Apyx Medical Forecast Models
Apyx Medical's time-series forecasting models are one of many Apyx Medical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Apyx Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Apyx Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Apyx Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Apyx shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Apyx Medical. By using and applying Apyx Stock analysis, traders can create a robust methodology for identifying Apyx entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | (0.41) | (0.39) | |
Operating Profit Margin | (0.33) | (0.31) | |
Net Loss | (0.36) | (0.34) | |
Gross Profit Margin | 0.64 | 0.38 |
Current Apyx Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Apyx analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Apyx analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
7.88 | Buy | 5 | Odds |
Most Apyx analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Apyx stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Apyx Medical, talking to its executives and customers, or listening to Apyx conference calls.
Apyx Stock Analysis Indicators
Apyx Medical stock analysis indicators help investors evaluate how Apyx Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Apyx Medical shares will generate the highest return on investment. By understating and applying Apyx Medical stock analysis, traders can identify Apyx Medical position entry and exit signals to maximize returns.
Begin Period Cash Flow | 10.2 M | |
Long Term Debt | 33.2 M | |
Common Stock Shares Outstanding | 34.6 M | |
Total Stockholder Equity | 26.7 M | |
Tax Provision | -2.4 M | |
Property Plant And Equipment Net | 7.1 M | |
Cash And Short Term Investments | 43.7 M | |
Cash | 43.7 M | |
Accounts Payable | 2.7 M | |
Net Debt | -5.2 M | |
50 Day M A | 1.2535 | |
Total Current Liabilities | 12.7 M | |
Other Operating Expenses | 69.6 M | |
Non Current Assets Total | 8.9 M | |
Non Currrent Assets Other | 1.7 M | |
Stock Based Compensation | 5.1 M |
Additional Tools for Apyx Stock Analysis
When running Apyx Medical's price analysis, check to measure Apyx Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apyx Medical is operating at the current time. Most of Apyx Medical's value examination focuses on studying past and present price action to predict the probability of Apyx Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apyx Medical's price. Additionally, you may evaluate how the addition of Apyx Medical to your portfolios can decrease your overall portfolio volatility.